HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zahir Amoura Selected Research

Non-Langerhans-Cell Histiocytosis (Histiocytosis, Non Langerhans Cell)

1/2018Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.
1/2017High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zahir Amoura Research Topics

Disease

57Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2022 - 02/2003
21Erdheim-Chester Disease
01/2022 - 10/2006
15COVID-19
12/2022 - 01/2020
12Neoplasms (Cancer)
12/2021 - 05/2005
10Connective Tissue Diseases (Connective Tissue Disease)
05/2022 - 11/2003
10Histiocytosis
01/2021 - 06/2008
10Thrombosis (Thrombus)
10/2020 - 03/2011
10Autoimmune Diseases (Autoimmune Disease)
05/2016 - 12/2003
9Sarcoidosis (Schaumann Disease)
12/2022 - 02/2006
9Infections
09/2022 - 07/2011
9Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
12/2021 - 10/2004
8Vasculitis (Vasculitides)
05/2021 - 12/2009
8Inflammation (Inflammations)
01/2019 - 02/2006
8Myositis (Idiopathic Inflammatory Myopathies)
05/2015 - 05/2005
7Hemorrhage
05/2021 - 10/2007
7Lupus Nephritis
01/2020 - 08/2004
7Systemic Scleroderma (Systemic Sclerosis)
01/2018 - 05/2010
5Rheumatic Diseases (Rheumatism)
09/2022 - 11/2012
5Catatonia
10/2021 - 04/2003
5Hypergammaglobulinemia (Hyperimmunoglobulinemia)
03/2014 - 03/2010
4Critical Illness (Critically Ill)
01/2022 - 01/2020
4Interstitial Lung Diseases (Interstitial Lung Disease)
12/2020 - 09/2012
4Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
11/2020 - 02/2013
4Antisynthetase syndrome
03/2017 - 09/2012
4Congenital heart block
12/2015 - 10/2004
3Disease Progression
11/2022 - 01/2020
3Relapsing Polychondritis
05/2022 - 05/2009
3Lymphopenia (Lymphocytopenia)
12/2021 - 05/2013
3Glomerulonephritis
01/2020 - 05/2016
3Myocarditis (Carditis)
01/2020 - 05/2006
3Neurosarcoidosis
05/2019 - 12/2016
3Thrombocytopenia (Thrombopenia)
01/2019 - 10/2004
3Rare Diseases (Rare Disease)
01/2018 - 07/2011
3Fibrosis (Cirrhosis)
01/2018 - 07/2012
3Paraproteinemias (Monoclonal Gammopathy)
10/2017 - 06/2010
3Neonatal Systemic lupus erythematosus
12/2015 - 02/2011
2Capillary Leak Syndrome
05/2022 - 10/2017
2Pure Red-Cell Aplasia
12/2021 - 01/2018
2Venous Thrombosis (Deep-Vein Thrombosis)
12/2021 - 10/2019
2Malnutrition (Nutritional Deficiencies)
06/2021 - 12/2020
2Purpura
05/2021 - 01/2021
2Cutaneous Lupus Erythematosus
04/2021 - 04/2015
2Fatigue
01/2021 - 01/2019
2Reinfection
01/2021 - 03/2017
2Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
10/2020 - 05/2016
2Granuloma
01/2020 - 02/2006

Drug/Important Bio-Agent (IBA)

27AntibodiesIBA
01/2022 - 10/2004
21Hydroxychloroquine (Plaquenil)FDA LinkGeneric
11/2022 - 11/2003
16Biological ProductsIBA
12/2021 - 11/2011
12AutoantibodiesIBA
01/2018 - 08/2004
10InterferonsIBA
01/2022 - 05/2010
8Adrenal Cortex Hormones (Corticosteroids)IBA
10/2021 - 07/2011
7Rituximab (Mabthera)FDA Link
10/2021 - 05/2009
7CytokinesIBA
01/2021 - 02/2006
6Pharmaceutical PreparationsIBA
05/2022 - 01/2008
6Mycophenolic Acid (Cellcept)FDA LinkGeneric
05/2022 - 05/2006
6Immunoglobulin G (IgG)IBA
01/2022 - 05/2008
6Antiphospholipid AntibodiesIBA
12/2021 - 12/2003
5Proteins (Proteins, Gene)FDA Link
05/2022 - 03/2010
5Phosphotransferases (Kinase)IBA
01/2020 - 02/2016
5SteroidsIBA
01/2018 - 12/2016
5VemurafenibIBA
07/2015 - 09/2012
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2022 - 05/2006
4Intravenous Immunoglobulins (IVIG)FDA Link
01/2022 - 05/2008
4Immunoglobulin A (IgA)IBA
05/2021 - 01/2018
4Estrogens (Estrogen)FDA Link
01/2021 - 01/2017
4Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2011
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020 - 02/2016
4Infliximab (Remicade)FDA Link
05/2019 - 05/2017
3GlucocorticoidsIBA
12/2022 - 11/2012
3Antirheumatic Agents (DMARD)IBA
11/2022 - 09/2012
3Immunosuppressive Agents (Immunosuppressants)IBA
09/2022 - 06/2017
3Immunoglobulins (Immunoglobulin)IBA
01/2022 - 03/2017
3AntigensIBA
01/2022 - 02/2006
3Immunoglobulin M (IgM)IBA
01/2022 - 07/2011
3EnzymesIBA
12/2021 - 09/2013
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2020 - 03/2011
3Azathioprine (Imuran)FDA LinkGeneric
01/2020 - 05/2006
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2019 - 03/2014
3Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2018 - 05/2013
3Monoclonal AntibodiesIBA
01/2017 - 05/2015
3Antinuclear AntibodiesIBA
01/2014 - 03/2011
3Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2013 - 09/2012
2VaccinesIBA
01/2022 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
12/2021 - 01/2017
2Oxygen (Dioxygen)IBA
06/2021 - 01/2021
2NivolumabIBA
06/2021 - 06/2017
2micaIBA
01/2021 - 11/2011
2Phospholipids (Phosphatides)FDA LinkGeneric
01/2021 - 01/2019
2rheinIBA
01/2021 - 01/2019
2belimumabIBA
11/2020 - 01/2020
2Prednisone (Sone)FDA LinkGeneric
01/2020 - 01/2015

Therapy/Procedure

26Therapeutics
01/2022 - 12/2002
6Plasma Exchange
10/2021 - 04/2003
3Critical Care (Surgical Intensive Care)
12/2021 - 01/2020
3Extracorporeal Membrane Oxygenation
02/2021 - 10/2010
2Renal Replacement Therapy (Therapies, Renal Replacement)
09/2022 - 02/2021
2Artificial Respiration (Mechanical Ventilation)
09/2022 - 01/2022
2Off-Label Use
05/2022 - 10/2017
2Erythrocyte Transfusion
12/2021 - 10/2020